You are currently viewing a new version of our website. To view the old version click .

Cancers | Top 10 Cited Papers in 2021 in the Section “Tumor Microenvironment”

12 October 2022

1. “Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy”
by Aboelella, N. S.; Brandle, C.; Kim, T.; Ding, Z.-C. and Zhou, G.
Cancers 2021, 13(5), 986; https://doi.org/10.3390/cancers13050986
Available online: https://www.mdpi.com/2072-6694/13/5/986

2. “The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression”
by García-Ortiz, A.; Rodríguez-García, Y.; Encinas, J.; Maroto-Martín, E.; Castellano, E.; Teixidó, J. and Martínez-López, J.
Cancers 2021, 13(2), 217; https://doi.org/10.3390/cancers13020217
Available online: http://www.mdpi.com/2072-6694/13/2/217

3. “The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer”
by Ribatti, D.; Solimando, A. G. and Pezzella, F.
Cancers 2021, 13(14), 3433; https://doi.org/10.3390/cancers13143433
Available online: http://www.mdpi.com/2072-6694/13/14/3433

4. “The Role of Hypoxia in Glioblastoma Radiotherapy Resistance”
by Chédeville, A. L. and Madureira, P. A.
Cancers 2021, 13(3), 542; https://doi.org/10.3390/cancers13030542
Available online: http://www.mdpi.com/2072-6694/13/3/542

5. “Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis”
by Datta, A.; Deng, S.; Gopal, V.; Yap, K. C.-H.; Halim, C. E.; Lye, M. L.; Ong, M. S.; Tan, T. Z.; Sethi, G.; Hooi, S. C.; Kumar, A. P. and Yap, C. T.
Cancers 2021, 13(8), 1882; https://doi.org/10.3390/cancers13081882
Available online: http://www.mdpi.com/2072-6694/13/8/1882

6. “Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma”
by Hanamura, I.
Cancers 2021, 13(2), 256; https://doi.org/10.3390/cancers13020256
Available online: http://www.mdpi.com/2072-6694/13/2/256

7. “Plasmin and Plasminogen System in the Tumor Microenvironment: Implications for Cancer Diagnosis, Prognosis, and Therapy”
by Bharadwaj, A. G.; Holloway, R. W.; Miller, V. A. and Waisman, D. M.
Cancers 2021, 13(8), 1838; https://doi.org/10.3390/cancers13081838
Available online: http://www.mdpi.com/2072-6694/13/8/1838

8. “Collagen Type XI Alpha 1 (COL11A1): A Novel Biomarker and a Key Player in Cancer”
by Nallanthighal, S.; Heiserman, J. P. and Cheon, D.-J.
Cancers 2021, 13(5), 935; https://doi.org/10.3390/cancers13050935
Available online: http://www.mdpi.com/2072-6694/13/5/935

9. “Cancer-Associated Fibroblast-Induced Resistance to Chemotherapy and Radiotherapy in Gastrointestinal Cancers”
by Ham, I.-H.; Lee, D. and Hur, H.
Cancers 2021, 13(5), 1172; https://doi.org/10.3390/cancers13051172
Available online: http://www.mdpi.com/2072-6694/13/5/1172

10. “Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer”
by Zahra, F. T.; Sajib, M. S. and Mikelis, C. M.
Cancers 2021, 13(6), 1422; https://doi.org/10.3390/cancers13061422
Available online: http://www.mdpi.com/2072-6694/13/6/1422